Yamcof LS Syrup is a combination pharmaceutical formulation containing Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), and Guaifenesin (50mg/5ml), designed for the management of respiratory conditions characterized by bronchospasm, mucus hypersecretion, and productive cough. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing bronchial smooth muscle, thereby alleviating bronchospasm and improving airflow in obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Ambroxol serves as a mucolytic agent that facilitates the breakdown and clearance of viscous mucus by enhancing mucociliary transport and stimulating surfactant production, which aids in reducing airway obstruction. Guaifenesin is an expectorant that promotes the liquefaction of respiratory secretions, facilitating easier expectoration and clearance of mucus from the airways. The synergistic action of these three active ingredients provides comprehensive symptomatic relief in conditions like bronchitis, asthma exacerbations, and other respiratory tract infections with excessive mucus production. Yamcof LS Syrup should be administered as per the prescribed dosage, with caution advised in patients with hypersensitivity to any components, cardiovascular disorders, or hyperthyroidism. It is contraindicated in patients with severe cardiac arrhythmias and should be used under medical supervision.